Agree. For me, the share price appreciation also will depend on whether the company can secure any Covid-19 vaccine business or not.
If its only depend on the current new businesses (test kit, tracvirus/safetravelpass,gloves, PPEs (gowns) and the Gua Musang subcontact), I think the price appreciation won't be to high.
As for 2021, the hype for Covid-19 vaccines counters will still kicking. If Nexgram can secure any Covid-19 vaccine business, whether it is for bottling or securing The VaccineLab-Rafarma JV, the price of the Nexgram's shares will be BOOM at an unexpected level He He
The Jan 2021 - April 2021 period will be the interesting period to be monitored concerning the prospect of Nexgram in securing Covid-19 vaccine business.
With the emergence of Rafarma Pharmaceuticals and its Russian subsidiary PJSC Kraspharma as a JV partner with VaccineLabs, Nexgram has a great chance to cater for the Russian Gamaleya Sputnik V vaccine business (in Malaysia or Indonesia).
I believe the management will ensure vaccine businesses secured to make all under one roof. That's the plan. And the last kick is from PN government that awarded contracts to Nexgram. MYR??? (U decide what price to off-load)
OKU_2020 Abd Rahim Osman Stim pulak 28/12/2020 11:33 AM +++++++++ Hang ni Osman Biaq Betoiii.... Silap ambeq ubat ni...Viagra Kaa ? Tut Tut Pak Tua gi mana ?...Apa nii...Cehhh Tak dak pekdah masuk sini , tut tut merengkok diam dalam almari baju ( closet ) !
Repost posting paktua73 yang terawal semasa dia join group NXGRAM. {{{{Dengan andaian keadaan tidak berubah}}}}. He He. . . paktua73, [12.12.20 10:16] morning all nxgram warriors.. after paktua study the rally pattern for nxgram.. this paktua own personal view..
nexgram will start rally on jan after all vaccines start hot
paktua will start fight here on mid jan
paktua73, [12.12.20 10:18] paktua aimed rm 0.50 on april (personal target yer)
...nexgram will start rally on jan after all vaccines start hot ***** (I believe it also depend on the incoming result of QR 1, 2021)
...paktua aimed rm 0.50 on april (personal target yer) ***** (I believe it depend on the actual results of the company's ability to secure the vaccine business)
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
MZM2511
4,549 posts
Posted by MZM2511 > 2020-12-26 22:05 | Report Abuse
Agree. For me, the share price appreciation also will depend on whether the company can secure any Covid-19 vaccine business or not.
If its only depend on the current new businesses (test kit, tracvirus/safetravelpass,gloves, PPEs (gowns) and the Gua Musang subcontact), I think the price appreciation won't be to high.
As for 2021, the hype for Covid-19 vaccines counters will still kicking. If Nexgram can secure any Covid-19 vaccine business, whether it is for bottling or securing The VaccineLab-Rafarma JV, the price of the Nexgram's shares will be BOOM at an unexpected level He He
The Jan 2021 - April 2021 period will be the interesting period to be monitored concerning the prospect of Nexgram in securing Covid-19 vaccine business.
With the emergence of Rafarma Pharmaceuticals and its Russian subsidiary PJSC Kraspharma as a JV partner with VaccineLabs, Nexgram has a great chance to cater for the Russian Gamaleya Sputnik V vaccine business (in Malaysia or Indonesia).
My great dreams for Nexgram. He He